key: cord-0823708-ixuptlyd
authors: Nadeem, Muhammad Faisal; Matti, Nazish; Parveen, Shagufta; Rafiq, Sehrish
title: Incessant threat of COVID-19 variants: Highlighting need for a mix of FDA-approved artificial intelligence tools and community pharmacy services
date: 2021-07-21
journal: Res Social Adm Pharm
DOI: 10.1016/j.sapharm.2021.07.018
sha: d35111ffe19ab735a1bcab342dac0bd41b1a86de
doc_id: 823708
cord_uid: ixuptlyd

Seamless integration of artificial intelligence (AI) technology, especially FDA-approved AI tools, in community pharmacies can build increasingly effective and easy care pathways, thereby minimizing burden on healthcare system, and ensuring compliance to preventive measure through limiting hospital visits. In this regard, the WHO needs to enlist and provide guidance on most promising AI tools that can be implemented in community pharmacy settings.

1 approved artificial intelligence tools and community pharmacy services 2 Most recently, the World Health Organization (WHO) and the International 3 Pharmaceutical Federation FIP) have published a guidance and a survey report, respectively, in 4 view of the emerging evidence-based potential of digital technologies, especially artificial 5 intelligence (AI), in enhancing the delivery of quality health care and medicine, increasing 6 patient safety and reducing healthcare costs 1, 2 . However, the WHO has also highlighted high 7 implementation cost, several safety concerns, and has issued caution about the use of AI without 8 expert supervision, robust technologies, and training. This clearly implies that the integration of 9 AI in major patient-related decisions or specialty areas demand a lot of evidence and monetary 10 resources. But we are of the opinion that easily available AI tools, especially approved by the US 11 Food and Drug Administration (FDA) 3 , could be beneficial beyond expectations in strengthening 12 collapsed healthcare system of developing countries 4 , if employed wisely. This editorial is 13 intended to highlight the urgent need for the push of AI in community pharmacies to deliver 14 healthcare services in a more organized and timely manner in resource deprived nations, as 15 pandemic is nowhere near finished and community pharmacies are the only healthcare entities 16 that can empower patients and communities to undertake control of their healthcare while 17 maintain social distancing protocols. 18 The Delta variant of SARS-CoV-2, classified as variant of concern (VOC) by the WHO, 19 and COVID-19 associated opportunistic infections among patients with co-morbidities have 20 highlighted the importance of management of chronic disease patients, such as diabetes, 21 hypertension and cardiovascular diseases. Under such catastrophic conditions, community 22 pharmacies can be upgraded using AI tools. For instance, improved accuracy of cardiovascular 23 J o u r n a l P r e -p r o o f risk prediction among patients with heart disease was reported in clinical settings using EHR 24 data 5 . Likewise, FDA-approved AI tools, such as DreaMed AdvisorPro (analyzes blood glucose 25 and insulin pump data), and the guardian™ connect system (predicting blood glucose changes) 26 can be used to manage diabetic patients, as they are vulnerable to COVID-19 associated 27 mucormycosis and other complications. 28 Treatment adherence is a cornerstone of patient health outcomes management. However, 29 the World Health Organization has deemed medication non-adherence an epidemic and has 30 called for effective, patient-specific approaches 6 . The COVID-19 lockdown has further 31 suppressed healthcare consultations, thereby potentially hindering patient-centered case. With 32 the integration of computer implemented patient medication review system, community 33 pharmacists can assess the patient compliance to the prescribed treatment and nudge patient 34 practices. According to reports, the incidence of non-adherence to treatment was lowered 35 considerably with the aid of Express Scripts, "Vik" (chatbot), and intervention of community 36 pharmacist using big data analysis techniques. 7,8 37 Given the fact that immunization and vaccination programs around the globe have been 38 greatly influenced due to ongoing bleak situation, the utilization of AI equipped community 39 pharmacies seems extremely value-added in preventing other public health crisis. In addition,  Up-skill community pharmacists in terms of clinical decision making  Help select better treatment strategies and promote appropriate medication use  Improved accuracy of risk prediction among patients with chronic diseases  Help in risk-benefit analysis and decision-making about whether to treat a person with a specific drug or not.

FDA-approved A.I.-based algorithms

Improving refill adherence in medicare patients with tailored and interactive mobile text messaging: pilot study

How machine learning is embedded to support clinician decision making: an analysis of FDA-approved medical devices

Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic

Advancing Pharmacy Service using Big Data -Are We Fully Utilising the Big Data's Potential Yet? Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Vik: A Chatbot to Support Patients with Chronic Diseases

Using artificial intelligence in health-system pharmacy practice: Finding new patterns that matter

Can machine-learning improve cardiovascular risk prediction using routine clinical data? PloS one

Effect of a Virtual Pharmacy Review Program: A Population Health Case Study

Le dossier pharmaceutique dans un service d'accueil des urgences: évaluation de son accessibilité et de son impact sur le niveau de connaissance du traitement du patient

Continuous monitoring in COVID-19 care: a retrospective study in time of crisis

References 76 1. International Pharmaceutical Federation. FIP digital health in pharmacy education. The Hague, 77 Netherlands: International Pharmaceutical Federation

Restructured society and environment: A review on potential 79 technological strategies to control the COVID-19 pandemic

How machine learning is embedded to support clinician 81 decision making: an analysis of FDA-approved medical devices

Why is Pakistan vulnerable to COVID-19 associated morbidity and mortality? A scoping 84 review

Can machine-learning improve cardiovascular risk 86 prediction using routine clinical data? PloS one

World Health Organization. Adherence to Long-term Therapies-Evidence for Action. Switzerland World 88 Health Organization

Advancing Pharmacy Service using Big Data -90

Are We Fully Utilising the Big Data's Potential Yet? Journal of Pharmacy & Pharmaceutical Sciences : a 91 publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences 92 pharmaceutiques

Using dispensing data to evaluate adherence implementation 94 rates in community pharmacy

Drug safety in Pakistan

COVID-19 and community pharmacy services in Pakistan: challenges, barriers and 98 solution for progress